Inhibitors of AKT activity

The present invention is directed to compounds which contain substituted napthyridines which inhibit the activity of Akt, a serine/threonine protein kinase. The invention is further directed to chemotherapeutic compositions containing the compounds of this invention and methods for treating cancer c...

Full description

Saved in:
Bibliographic Details
Main Author BILODEAU MARK T.,CHEN CHIXU,COSFORD NICHOLAS D. P.,EASTMAN BRIAN W.,HARTNETT JOHN C.,HU ESSA H.,MANLEY PETER J.,NEILSON LOU ANNE,TEHRANI LIDA R.,WU ZHICAI
Format Patent
LanguageEnglish
Published 04.04.2007
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The present invention is directed to compounds which contain substituted napthyridines which inhibit the activity of Akt, a serine/threonine protein kinase. The invention is further directed to chemotherapeutic compositions containing the compounds of this invention and methods for treating cancer comprising administration of the compounds of the invention.
AbstractList The present invention is directed to compounds which contain substituted napthyridines which inhibit the activity of Akt, a serine/threonine protein kinase. The invention is further directed to chemotherapeutic compositions containing the compounds of this invention and methods for treating cancer comprising administration of the compounds of the invention.
Author BILODEAU MARK T.,CHEN CHIXU,COSFORD NICHOLAS D. P.,EASTMAN BRIAN W.,HARTNETT JOHN C.,HU ESSA H.,MANLEY PETER J.,NEILSON LOU ANNE,TEHRANI LIDA R.,WU ZHICAI
Author_xml – fullname: BILODEAU MARK T.,CHEN CHIXU,COSFORD NICHOLAS D. P.,EASTMAN BRIAN W.,HARTNETT JOHN C.,HU ESSA H.,MANLEY PETER J.,NEILSON LOU ANNE,TEHRANI LIDA R.,WU ZHICAI
BookMark eNrjYmDJy89L5WSQ8szLyEzKLMkvKlbIT1Nw9A5RSEwuySzLLKnkYWBNS8wpTuWF0twM8m6uIc4euqkF-fGpxQWJyal5qSXxzn6GliZGJuYGjsaEVQAAaJcjjg
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID CN1942470A
GroupedDBID EVB
ID FETCH-epo_espacenet_CN1942470A3
IEDL.DBID EVB
IngestDate Fri Jul 19 15:56:59 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_CN1942470A3
Notes Application Number: CN200580011984
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20070404&DB=EPODOC&CC=CN&NR=1942470A
ParticipantIDs epo_espacenet_CN1942470A
PublicationCentury 2000
PublicationDate 20070404
PublicationDateYYYYMMDD 2007-04-04
PublicationDate_xml – month: 04
  year: 2007
  text: 20070404
  day: 04
PublicationDecade 2000
PublicationYear 2007
RelatedCompanies MERCK & CO. INC
RelatedCompanies_xml – name: MERCK & CO. INC
Score 2.6675398
Snippet The present invention is directed to compounds which contain substituted napthyridines which inhibit the activity of Akt, a serine/threonine protein kinase....
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title Inhibitors of AKT activity
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20070404&DB=EPODOC&locale=&CC=CN&NR=1942470A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV3NT8IwFH9BNOpNUYP4tYPZrXHpxrodFiPdFjRhEIOGG2m3LuwyiMzw7_M6mXrh1rTJ60f66_vuA3h0hZKum2cktS1JkOMp4nu-IF5OPWRPrqKWzkYeJe7ww3mb9WctWDS5MPU_oZv6c0REVIp4r-r3evVnxArr2Mr1kyywa_kcT4PQbLRjhnfSMcNBEE3G4ZibnAc8MZP3AHV16jDr5QAOUYhmGgvR50DnpKz-M5T4DI4mSKuszqGlyg6c8KbuWgeORzt3NzZ3yFtfQO-1XBSy0LVxjGVuoGhm6JQEXfnhEh7iaMqHBCeZ_-5nzpNmNfYVtFHLV10wEGmM5SjMCNSIUosKO9NOOj-nGRXMSa-hu49Kb__QDZz-GCN1tMkttKuvb3WHXLSS9_UBbAE6UXUu
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV3NT4MwFH-Z0zhvOjVzfoyD4UYkhVE4EOMKhOlgi0GzG-GjZFzY4jD--77iUC-7NW3y-pH--r77AO6NhKeGUeRKpqmpghyPK5ZpJYpZEBPZk8GJKrKRg9Dw3_Tn5XjZgVWbC9P8E_rVfI6IiMoQ73XzXm_-jFhOE1u5fUhL7Fo_epHtyK12TPFO6rIzsd3F3JkzmTGbhXL4aqOuTnSqPh3AIQrYVGDBfZ-InJTNf4bincLRAmlV9Rl0eNWHHmvrrvXhONi5u7G5Q972HIbTalWmpaiNI60LCUUzSaQkiMoPFzDy3Ij5Ck4S_-4nZmG7Gu0Suqjl8wFIiDRKCxRmEtSIMpUkWi6cdFZBcpJQPbuCwT4qw_1DI-j5UTCLZ9Pw5RpOfgyTIvLkBrr1xye_RY5ap3fNYXwD4094IQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Inhibitors+of+AKT+activity&rft.inventor=BILODEAU+MARK+T.%2CCHEN+CHIXU%2CCOSFORD+NICHOLAS+D.+P.%2CEASTMAN+BRIAN+W.%2CHARTNETT+JOHN+C.%2CHU+ESSA+H.%2CMANLEY+PETER+J.%2CNEILSON+LOU+ANNE%2CTEHRANI+LIDA+R.%2CWU+ZHICAI&rft.date=2007-04-04&rft.externalDBID=A&rft.externalDocID=CN1942470A